Quick Answer
A particle-containing cosmetic formula needs a review of the actual dispenser pathway and representative filled samples. Identify the formula revision, relevant suspended ingredients and preparation history with the formulator. Record what reaches the outlet as well as the amount delivered. Neither an airless label nor a large visible opening establishes suitability for every suspension.
A serum can look fluid while containing visible effects, dispersed solids or material that changes distribution during storage. A clear liquid demonstration therefore cannot answer every question about its pump. The trial brief should describe the actual material and the user action the brand intends to support.
Give the supplier usable formula information
Ask the formulation team which particle features and flow information matter to dispensing. Provide the available controlled description through the agreed confidential exchange. Do not replace it with a marketing category such as glitter serum or exfoliating lotion, and do not invent a maximum particle dimension when the supplier has not defined one.
Identify the current formula revision and production-intent bulk preparation. A base formula before the suspended ingredient was added is a different trial material. It can support a limited setup check, but should not approve the final formula merely because both samples have the same product name.
The broader airless mechanism guide identifies particles as a selection consideration. This article concerns sample representativeness and observation, not another general viscosity ranking.
Describe the sample before it reaches the bottle
Have the formulator define any required mixing, resting and handling procedure. Record what was actually done before filling, including changes during transfer. Do not assume that freshly stirred material represents a bottle used after storage, or instruct operators to shake every airless pack as a universal correction.
If the formulation shows a visible distribution change, record its location and elapsed conditions. The responsible formulation team should interpret whether that behaviour is expected and what preparation is appropriate. A photograph alone cannot diagnose an unstable formula or prove a packaging fault.
| Trial input | Record | Keep separate |
|---|---|---|
| Formula identity | Revision, batch and relevant suspended features | Earlier base versus finished formula |
| Preparation | Actual approved mixing and resting history | Planned procedure versus unrecorded intervention |
| Filling | Transfer, fill quantity and assembly conditions | Bulk condition versus condition in each pack |
| Dispensing | Individual strokes and collected observations | Total amount versus delivered composition appearance |
| Later use | Storage and relevant fill-state history | Initial success versus subsequent behaviour |
Review the complete product path
Request the proposed pump, actuator and relevant contact-component references. Ask the supplier what pathway information it needs to assess the material. The visible outlet is only one part of the assembly; judging fit from that opening alone leaves the internal proposal unresolved.
Do not enlarge, remove or clean components informally to obtain a successful demonstration. A controlled modification can be evaluated as a new configuration if authorised, but the result must remain linked to the changed parts. It does not qualify the original proposal.
Observe the delivered material, not only a total weight
Define the actuation sequence and collection method with the responsible teams. Record incomplete delivery, a changed pattern, visible residue and differences between individual strokes. Preserve unsuccessful operations. A favourable average can hide an intermittent interruption that matters to the user.
Where relevant, have the formulation team define how it will examine the material delivered at different stages. A similar total mass does not by itself establish that the intended suspended effect is presented consistently. Do not claim a concentration result from a visual check; identify the method and reviewer needed for that question.
Keep output, component condition and formula observations connected through sample identity. If the actuator cannot complete its movement, distinguish that observation from an outlet that releases a different-looking material. These symptoms need review rather than an immediate declaration that every problem is clogging.
Illustrative comparison: fresh mixing hides later behaviour
Imagine a technician fills samples from recently mixed bulk and observes acceptable initial dispensing. A later sample is operated after an undocumented rest and gives a different appearance. This is a hypothetical planning example, not an Oulete result or a diagnosis of settling.
The team should reconstruct preparation and storage, preserve the samples and agree a repeatable comparison. If a preparation instruction is revised, record that change and review whether it matches intended consumer use. Do not silently remix the failed sample and replace the original observation with a pass.
Set a decision for each candidate
Record the approved configuration, material history, trial method and project-specific criteria. A successful first-use trial may justify continued development while later-use or compatibility questions remain open. Keep those stages visible in the sample approval record.
For plastic airless bottle projects, Oulete’s starting MOQ is 5,000 pieces. That is not evidence that every pump can handle suspended solids or that specialist dispenser development is included. Send the intended application, existing formula information and requested observation scope through the packaging enquiry page, then agree the controlled technical exchange.
Buyer Questions
Can viscosity alone approve a suspension?
No. Keep relevant suspended features, actual preparation and complete-pack results in the review.
Does a larger outlet solve every interruption?
No. Ask the supplier to assess the complete identified pathway and preserve the observed sample before changes.